Monotherapeutic high-dose-rate brachytherapy for prostate cancer: Five-year results of an extreme hypofractionation regimen with 54 GY in nine fractions

International Journal of Radiation Oncology Biology Physics

Volumn 80, Issue 2, 2011, Pages 469-475

  Yoshioka, Yasuo ^a   Konishi, Koji ^a   Sumida, Iori ^a   Takahashi, Yutaka ^a   Isohashi, Fumiaki ^a   Ogata, Toshiyuki ^a   Koizumi, Masahiko ^a   Yamazaki, Hideya ^b   Nonomura, Norio ^a   Okuyama, Akihiko ^a   Inoue, Takehiro ^a  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

Author keywords

HDR; High dose rate brachytherapy; Hypofractionation; Monotherapy; Prostate cancer; Radiotherapy

Indexed keywords

HDR; HIGH-DOSE RATE BRACHYTHERAPY; HYPOFRACTIONATION; MONO-THERAPY; PROSTATE CANCER;

DISEASE CONTROL; DISEASES; ONCOLOGY; RADIOTHERAPY;

TOXICITY;

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; BRACHYTHERAPY; CANCER CONTROL; DISEASE FREE SURVIVAL; EXTERNAL BEAM RADIOTHERAPY; HORMONAL THERAPY; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; PROSTATE CANCER; RADIATION DOSE; RADIATION DOSE FRACTIONATION;

AGED; AGED, 80 AND OVER; ANDROGEN ANTAGONISTS; BRACHYTHERAPY; CONFIDENCE INTERVALS; DISEASE-FREE SURVIVAL; DOSE FRACTIONATION; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; RADIATION INJURIES; SURVIVAL RATE;

EID: 79955571563     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2010.02.013     Document Type: Article

References (37)

1. S. Nag, D. Beyer, and J. Friedland American Brachytherapy Society (ABS) recommendations for transperineal permanent brachytherapy of prostate cancer Int J Radiat Oncol Biol Phys 44 1999 789 799 (Pubitemid 29284127)
2. D. Ash, A. Flynn, and J. Battermann ESTRO/EAU/EORTC recommendations on permanent seed implantation for localized prostate cancer Radiother Oncol 57 2000 315 321
3. R.M. Galalae, G. Kovacs, and J. Schultze Long-term outcome after elective irradiation of the pelvic lymphatics and local dose escalation using high-dose-rate brachytherapy for locally advanced prostate cancer Int J Radiat Oncol Biol Phys 52 2002 81 90 (Pubitemid 34044108)
4. G. Borghede, H. Hedelin, and S. Holmang Combined treatment with temporary short-term high dose rate iridium-192 brachytherapy and external beam radiotherapy for irradiation of localized prostatic carcinoma Radiother Oncol 44 1997 237 244 (Pubitemid 27405147)
5. T.P. Mate, J.E. Gottesman, and J. Hatton High dose-rate afterloading Ir-192 prostate brachytherapy: Feasibility report Int J Radiat Oncol Biol Phys 41 1998 525 533 (Pubitemid 28275080)
6. D.J. Demanes, R.R. Rodriguez, and L. Schour High-dose-rate intensity-modulated brachytherapy with external beam radiotherapy for prostate cancer: California endocurietherapy's 10-year results Int J Radiat Oncol Biol Phys 61 2005 1306 1316 (Pubitemid 40470411)
7. A. Martinez, J. Gonzalez, and J. Stromberg Conformal prostate brachytherapy: Initial experience of a phase I/II dose escalating trial Int J Radiat Oncol Biol Phys 33 1995 1019 1027
8. S. Dinges, S. Deger, and S. Koswig High-dose rate interstitial with external beam irradiation for localized prostate cancer - Results of a prospective trial Radiother Oncol 48 1998 197 202 (Pubitemid 28423792)
9. J. Hiratsuka, Y. Jo, and K. Yoshida Clinical results of combined treatment conformal high-dose-rate iridium-192 brachytherapy and external beam radiotherapy using staging lymphadenectomy for localized prostate cancer Int J Radiat Oncol Biol Phys 59 2004 684 690 (Pubitemid 38748733)
10. Y. Yoshioka, T. Nose, and K. Yoshida High-dose-rate interstitial brachytherapy as a monotherapy for localized prostate cancer: Treatment description and preliminary results of a phase I/II clinical trial Int J Radiat Oncol Biol Phys 48 2000 675 681
11. Y. Yoshioka, T. Nose, and K. Yoshida High-dose-rate brachytherapy as monotherapy for localized prostate cancer: A retrospective analysis with special focus on tolerance and chronic toxicity Int J Radiat Oncol Biol Phys 56 2003 213 220 (Pubitemid 36403694)
12. Y. Yoshioka, K. Konishi, and R.J. Oh High-dose-rate brachytherapy without external beam irradiation for locally advanced prostate cancer Radiother Oncol 80 2006 62 68 (Pubitemid 44226435)
13. A. Martinez, I. Pataki, and G. Edmundson Phase II prospective study of the use of conformal high-dose-rate brachytherapy as monotherapy for the treatment of favorable stage prostate cancer: A feasibility report Int J Radiat Oncol Biol Phys 49 2001 61 69 (Pubitemid 32041277)
14. T. Martin, D. Baltas, and R. Kurek 3-D conformal HDR brachytherapy as monotherapy for localized prostate cancer: A pilot study Strahlenther Onkol 180 2004 225 232 (Pubitemid 38461547)
15. C. Corner, A.M. Rojas, and L. Bryant A Phase II study of high-dose-rate afterloading brachytherapy as monotherapy for the treatment of localized prostate cancer Int J Radiat Oncol Biol Phys 72 2008 441 446
16. J.F. Fowler The linear-quadratic formula and progress in fractionated radiotherapy Br J Radiol 62 1989 679 694 (Pubitemid 19194494)
17. D.J. Brenner, and E.J. Hall Fractionation and protraction for radiotherapy of prostate carcinoma Int J Radiat Oncol Biol Phys 43 1999 1095 1101 (Pubitemid 29144800)
18. M. Roach III, G. Hanks, and H. Thames Jr. Defining biochemical failure following radiotherapy with or without hormonal therapy in men with clinically localized prostate cancer: Recommendations of the RTOG-ASTRO Phoenix Consensus Conference Int J Radiat Oncol Biol Phys 65 2006 965 974
19. National Cancer Institute Common Terminology Criteria for Adverse Events, version 3.0 Available from: www.ctep.info.nih.gov/protocolDevelopment/ electronic-applications/docs/ctcaev3.pdf Accessed October 9, 2009
20. E.L. Kaplan, and P. Meier Nonparametric estimation from incomplete observation J Am Stat Assoc 53 1958 457 481
21. A. Pollack, G.K. Zagars, and L.G. Smith Preliminary results of a randomized radiotherapy dose-escalation study comparing 70 Gy with 78 Gy for prostate cancer J Clin Oncol 18 2000 3904 3911
22. L. Aström, D. Pedersen, and C. Mercke Long-term outcome of high dose rate brachytherapy in radiotherapy of localised prostate cancer Radiother Oncol 74 2005 157 161 (Pubitemid 40331872)
23. C.E. Vargas, A.A. Martinez, and T.P. Boike High-dose irradiation for prostate cancer via a high-dose-rate brachytherapy boost: Results of a phase I to II study Int J Radiat Oncol Biol Phys 66 2006 416 423 (Pubitemid 44332728)
24. S. Deger, D. Boehmer, and J. Roigas High dose rate (HDR) brachytherapy with conformal radiation therapy for localized prostate cancer Eur Urol 47 2005 441 448 (Pubitemid 40357885)
25. I.C. Hsu, B. Pickett, and K. Shinohara Normal tissue dosimetric comparison between HDR prostate implant boost and conformal external beam radiotherapy boost: Potential for dose escalation Int J Radiat Oncol Biol Phys 46 2000 851 858 (Pubitemid 30114396)
26. Y. Wang, R. Sankreacha, and A. Al-Hebshi Comparative study of dosimetry between high-dose-rate and permanent prostate implant brachytherapies in patients with prostate adenocarcinoma Brachytherapy 5 2006 251 255 (Pubitemid 44752111)
27. G. Kovacs, R. Potter, and T. Loch GEC/ESTRO-EAU recommendations on temporary brachytherapy using stepping sources for localised prostate cancer Radiother Oncol 74 2005 137 148 (Pubitemid 40331870)
28. Y. Yoshioka, T. Nishimura, and M. Kamata Evaluation of anatomy-based dwell position and inverse optimization in high-dose-rate brachytherapy of prostate cancer: A dosimetric comparison to a conventional cylindrical dwell position, geometric optimization, and dose-point optimization Radiother Oncol 75 2005 311 317 (Pubitemid 41007977)
29. M.J. Zelefsky, Z. Fuks, and M. Hunt High-dose intensity modulated radiation therapy for prostate cancer: Early toxicity and biochemical outcome in 772 patients Int J Radiat Oncol Biol Phys 53 2002 1111 1116 (Pubitemid 34787844)
30. H. Lukka, C. Hayter, and J.A. Julian Randomized trial comparing two fractionation schedules for patients with localized prostate cancer J Clin Oncol 23 2005 6132 6138
31. E.E. Yeoh, R.H. Holloway, and R.J. Fraser Hypofractionated versus conventionally fractionated radiation therapy for prostate carcinoma: Updated results of a phase III randomized trial Int J Radiat Oncol Biol Phys 66 2006 1072 1083 (Pubitemid 44633501)
32. P.A. Kupelian, T.R. Willoughby, and C.A. Reddy Hypofractionated intensity-modulated radiotherapy (70 Gy at 2.5 Gy per fraction) for localized prostate cancer: Cleveland Clinic experience Int J Radiat Oncol Biol Phys 68 2007 1424 1430 (Pubitemid 47176809)
33. W.R. Lee Extreme hypofractionation for prostate cancer Expert Rev Anticancer Ther 9 2009 61 65
34. B.L. Madsen, R.A. Hsi, and H.T. Pham Stereotactic hypofractionated accurate radiotherapy of the prostate (SHARP), 33.5 Gy in five fractions for localized disease: First clinical trial results Int J Radiat Oncol Biol Phys 67 2007 1099 1105
35. C.R. King, J.D. Brooks, and H. Gill Stereotactic body radiotherapy for localized prostate cancer: Interim results of a prospective phase II clinical trial Int J Radiat Oncol Biol Phys 73 2009 1043 1048
36. K. Konishi, Y. Yoshioka, and F. Isohashi Correlation between dosimetric parameters and late rectal and urinary toxicities in patients treated with high-dose-rate brachytherapy used as monotherapy for prostate cancer Int J Radiat Oncol Biol Phys 75 2009 1003 1007
37. Y. Yoshioka, O. Suzuki, and K. Kobayashi External-beam radiotherapy for clinically localized prostate cancer in Osaka, Japan, 1995-2006: Time trends, outcome, and risk stratification Strahlenther Onkol 185 2009 446 452